Hussein El Hakim, managing director for Bayer Saudi Arabia and general manager for its pharmaceuticals division in the country, discusses the affiliate’s rapid expansion after years of double-digit growth. El Hakim explains how the German Life Science company is approaching the transformation of the Saudi healthcare market, with changes in the procurement process, advances in digitalization, and improved market access for innovative products.
[Vision 2030] is compelling because it is leading the transformation from an oil-based economy to a knowledge-based economy. In doing so, the country put its healthcare system, patient access to medicine, and digital capabilities at the centre
